Concure Oncology Revenue and Competitors

Concure Oncology specializes in early-stage breast cancer treatment and related services. Concure Oncology provides the technology, protocol, and equipment used by medical partners to perform the Breast Microseed Treatment (BMT), our early-stage, post lumpectomy breast cancer procedure. BMT combines a medical device, technology, and treatment procedure to deliver radiation therapy to patients with early-stage breast cancer. With Breast Microseed Treatment, side effects are less severe, and because it is administered in a one-time, one-hour treatment, a quicker, simpler return to health and wellness becomes possible. Concure Oncology is committed to easing the burden for women facing early-stage breast cancer by enhancing and simplifying radiation treatment so they can get back to living their lives.